first glp 1 on market BREAKING: The FDA has approved the oral GLP-1 pill for obesity, marking a major milestone in the weight-loss drug and a potential inflection point for treatment access. The daily pill What's next for GLP-1 innovation:

Side Effects: Excessive doses may cause neuromuscular weakness and, in severe cases, respiratory arrest, particularly when administered rapidly by infusion

Doctors aren't exactly sure how the drugs work "We know these medicines play on a receptor in the brainthe hypothalamusand we know that regulates our appetite, but scientists haven't figured out the precise mechanism for the way these medicines do that," Khan says

Colbert said, "Mounjaro or Tirzepatide turns off two key appetite hormones, and then the new one's coming out, the Retatrutide, which comes out probably next year, turns off three." In addition, Colbert described how patients experience slower digestion

A gas phase fractionation (GPF) library was also acquired by injecting a pool of all samples 8 times in order to cover a 350910 m/z precursor mass range using 35 DIA windows of 2 m/z with a 0.1 m/z overlap

It is essential to have a functional medicine-based approach to dealing with candida overgrowth